世界のエピゲノミクス市場は2023年に約20億5,000万米ドルと評価され、2024年から2032年の予測期間にわたって14.97%を超える健全な成長率で成長すると予想されています。
エピゲノミクスは、細胞の遺伝物質に対するエピジェネティックな修飾の完全なセットを研究する学問です。この修飾は、基礎となる DNA 配列を変更することなく遺伝子発現に影響を与えることができます。DNAメチル化やヒストン修飾などのこれらの修飾は、遺伝子のオン/オフの切り替えに影響し、遺伝したり環境要因によって影響を受けたりします。エピゲノミクスは、ゲノム全体にわたってこれらの変化を調べることで、これらの調節メカニズムが発達、疾患、および個体間の変異にどのように影響するかを理解しようとします。この分野は、さまざまな疾患に対する遺伝子調節と潜在的な治療ターゲットに関する洞察を提供します。
エピジェネティクスの研究の増加と慢性疾患の発生率の上昇は、市場の成長を促進する主な原動力です。この急成長分野は、遺伝子発現調節の複雑なメカニズムを解明する可能性に駆り立てられ、研究者、臨床医、業界リーダーを魅了してきました。この研究の急増は、特にがん、神経疾患、心血管疾患などの複雑な疾患の早期発見、予後評価、治療の層別化を促進するエピジェネティックマーカーを特定できるという期待によって推進されています。さらに、科学界と一般大衆の間でエピゲノミクスに対する認識と理解が高まったことで、この分野への関心と投資が促進されました。エピゲノミクス研究への公的および民間の資金が急増し、研究者にエピジェネティック調節の複雑さをさらに深く掘り下げるために必要なリソースを提供しています。この関心の高まりと多額の投資が相まって、エピゲノミクス市場の成長が推進されています。
世界のエピゲノミクス市場の主要地域には、北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東およびアフリカが含まれます。2023年には、高度な研究インフラ、バイオテクノロジーへの多額の投資、科学研究への強力な資金提供の組み合わせにより、北アメリカが収益の面でエピゲノミクス市場を支配しました。この地域の主要な学術研究機関は、エピゲノミクスの革新を推進し、新しい技術と治療法の開発を促進しています。さらに、北アメリカ諸国は、確立されたバイオテクノロジー企業のネットワークと、政府および民間部門の資金からの強力なサポートの恩恵を受けており、市場の成長をさらに後押ししています。業界の主要プレーヤーの存在と、研究機関とバイオテクノロジー企業間のコラボレーションの増加も、エピゲノミクス分野における地域のリーダーシップに貢献しています。さらに、アジア太平洋地域では、2024年から2032年の予測期間中に最も速いCAGR成長が期待されています。
目次
Table of Contents
Chapter 1. Global Epigenomics Market Executive Summary
1.1. Global Epigenomics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Technology
1.3.3. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Epigenomics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Epigenomics Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Research in Epigenetics
3.1.2. Rising Incidence of Chronic Diseases
3.1.3. Advancements in Epigenetic Technologies
3.2. Market Challenges
3.2.1. High Cost of Epigenetic Research
3.2.2. Complexity of Epigenetic Mechanisms
3.3. Market Opportunities
3.3.1. Personalized Medicine Advancements
3.3.2. Interdisciplinary Collaborations
3.3.3. Public and Private Funding Increases
Chapter 4. Global Epigenomics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Epigenomics Market Size & Forecasts by Product Type 2022-2032
5.1. Segment Dashboard
5.2. Global Epigenomics Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Reagents
5.2.2. Kits
5.2.3. Enzymes
5.2.4. Others
Chapter 6. Global Epigenomics Market Size & Forecasts by Technology 2022-2032
6.1. Segment Dashboard
6.2. Global Epigenomics Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. DNA Methylation
6.2.2. Histone Methylation
6.2.3. Histone Acetylation
6.2.4. MicroRNA Modification
6.2.5. Large Non-coding RNA
6.2.6. Chromatin Structures
6.2.7. Others
Chapter 7. Global Epigenomics Market Size & Forecasts by Application 2022-2032
7.1. Segment Dashboard
7.2. Global Epigenomics Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Pharmaceutical
7.2.2. Diagnostics
Chapter 8. Global Epigenomics Market Size & Forecasts by Region 2022-2032
8.1. North America Epigenomics Market
8.1.1. U.S. Epigenomics Market
8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
8.1.1.2. Technology breakdown size & forecasts, 2022-2032
8.1.1.3. Application breakdown size & forecasts, 2022-2032
8.1.2. Canada Epigenomics Market
8.1.2.1. Product Type breakdown size & forecasts, 2022-2032
8.1.2.2. Technology breakdown size & forecasts, 2022-2032
8.1.2.3. Application breakdown size & forecasts, 2022-2032
8.2. Europe Epigenomics Market
8.2.1. U.K. Epigenomics Market
8.2.1.1. Product Type breakdown size & forecasts, 2022-2032
8.2.1.2. Technology breakdown size & forecasts, 2022-2032
8.2.1.3. Application breakdown size & forecasts, 2022-2032
8.2.2. Germany Epigenomics Market
8.2.2.1. Product Type breakdown size & forecasts, 2022-2032
8.2.2.2. Technology breakdown size & forecasts, 2022-2032
8.2.2.3. Application breakdown size & forecasts, 2022-2032
8.2.3. France Epigenomics Market
8.2.3.1. Product Type breakdown size & forecasts, 2022-2032
8.2.3.2. Technology breakdown size & forecasts, 2022-2032
8.2.3.3. Application breakdown size & forecasts, 2022-2032
8.2.4. Spain Epigenomics Market
8.2.4.1. Product Type breakdown size & forecasts, 2022-2032
8.2.4.2. Technology breakdown size & forecasts, 2022-2032
8.2.4.3. Application breakdown size & forecasts, 2022-2032
8.2.5. Italy Epigenomics Market
8.2.5.1. Product Type breakdown size & forecasts, 2022-2032
8.2.5.2. Technology breakdown size & forecasts, 2022-2032
8.2.5.3. Application breakdown size & forecasts, 2022-2032
8.2.6. Rest of Europe Epigenomics Market
8.2.6.1. Product Type breakdown size & forecasts, 2022-2032
8.2.6.2. Technology breakdown size & forecasts, 2022-2032
8.2.6.3. Application breakdown size & forecasts, 2022-2032
8.3. Asia-Pacific Epigenomics Market
8.3.1. China Epigenomics Market
8.3.1.1. Product Type breakdown size & forecasts, 2022-2032
8.3.1.2. Technology breakdown size & forecasts, 2022-2032
8.3.1.3. Application breakdown size & forecasts, 2022-2032
8.3.2. India Epigenomics Market
8.3.2.1. Product Type breakdown size & forecasts, 2022-2032
8.3.2.2. Technology breakdown size & forecasts, 2022-2032
8.3.2.3. Application breakdown size & forecasts, 2022-2032
8.3.3. Japan Epigenomics Market
8.3.3.1. Product Type breakdown size & forecasts, 2022-2032
8.3.3.2. Technology breakdown size & forecasts, 2022-2032
8.3.3.3. Application breakdown size & forecasts, 2022-2032
8.3.4. Australia Epigenomics Market
8.3.4.1. Product Type breakdown size & forecasts, 2022-2032
8.3.4.2. Technology breakdown size & forecasts, 2022-2032
8.3.4.3. Application breakdown size & forecasts, 2022-2032
8.3.5. South Korea Epigenomics Market
8.3.5.1. Product Type breakdown size & forecasts, 2022-2032
8.3.5.2. Technology breakdown size & forecasts, 2022-2032
8.3.5.3. Application breakdown size & forecasts, 2022-2032
8.3.6. Rest of Asia Pacific Epigenomics Market
8.3.6.1. Product Type breakdown size & forecasts, 2022-2032
8.3.6.2. Technology breakdown size & forecasts, 2022-2032
8.3.6.3. Application breakdown size & forecasts, 2022-2032
8.4. Latin America Epigenomics Market
8.4.1. Brazil Epigenomics Market
8.4.1.1. Product Type breakdown size & forecasts, 2022-2032
8.4.1.2. Technology breakdown size & forecasts, 2022-2032
8.4.1.3. Application breakdown size & forecasts, 2022-2032
8.4.2. Mexico Epigenomics Market
8.4.2.1. Product Type breakdown size & forecasts, 2022-2032
8.4.2.2. Technology breakdown size & forecasts, 2022-2032
8.4.2.3. Application breakdown size & forecasts, 2022-2032
8.4.3. Rest of Latin America Epigenomics Market
8.4.3.1. Product Type breakdown size & forecasts, 2022-2032
8.4.3.2. Technology breakdown size & forecasts, 2022-2032
8.4.3.3. Application breakdown size & forecasts, 2022-2032
8.5. Middle East & Africa Epigenomics Market
8.5.1. Saudi Arabia Epigenomics Market
8.5.1.1. Product Type breakdown size & forecasts, 2022-2032
8.5.1.2. Technology breakdown size & forecasts, 2022-2032
8.5.1.3. Application breakdown size & forecasts, 2022-2032
8.5.2. South Africa Epigenomics Market
8.5.2.1. Product Type breakdown size & forecasts, 2022-2032
8.5.2.2. Technology breakdown size & forecasts, 2022-2032
8.5.2.3. Application breakdown size & forecasts, 2022-2032
8.5.3. Rest of Middle East & Africa Epigenomics Market
8.5.3.1. Product Type breakdown size & forecasts, 2022-2032
8.5.3.2. Technology breakdown size & forecasts, 2022-2032
8.5.3.3. Application breakdown size & forecasts, 2022-2032
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Novartis AG
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Abbott Laboratories
9.3.3. Abcam plc
9.3.4. Zymo Research Corporation
9.3.5. Agilent Technologies Inc.
9.3.6. Epizyme Inc.
9.3.7. Boehringer Ingelheim International GmbH
9.3.8. Bayer AG
9.3.9. Thermo Fisher Scientific Inc.
9.3.10. Illumina Inc.
9.3.11. Merck KGaA
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Global Epigenomics market, report scope
TABLE 2. Global Epigenomics market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Epigenomics market estimates & forecasts by Product Type 2022-2032 (USD Billion)
TABLE 4. Global Epigenomics market estimates & forecasts by Technology 2022-2032 (USD Billion)
TABLE 5. Global Epigenomics market estimates & forecasts by Application 2022-2032 (USD Billion)
TABLE 6. Global Epigenomics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Epigenomics market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. U.S. Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. U.S. Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 10. Canada Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Canada Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 12. UK Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. UK Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 14. Germany Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. Germany Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 16. France Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 17. France Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Spain Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Spain Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Italy Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 21. Italy Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 22. China Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 23. China Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 24. India Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 25. India Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 26. Japan Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 27. Japan Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 28. Australia Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 29. Australia Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 30. South Korea Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 31. South Korea Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 32. Brazil Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 33. Brazil Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 34. Mexico Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 35. Mexico Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 36. Saudi Arabia Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 37. Saudi Arabia Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 38. South Africa Epigenomics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 39. South Africa Epigenomics market estimates & forecasts by segment 2022-2032 (USD Billion)
…..
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Epigenomics market, research methodology
FIG 2. Global Epigenomics market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Epigenomics market, key trends 2023
FIG 5. Global Epigenomics market, growth prospects 2022-2032
FIG 6. Global Epigenomics market, porters 5 force model
FIG 7. Global Epigenomics market, PESTEL analysis
FIG 8. Global Epigenomics market, value chain analysis
FIG 9. Global Epigenomics market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Epigenomics market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Epigenomics market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Epigenomics market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Epigenomics market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Epigenomics market, regional snapshot 2022 & 2032
FIG 15. North America Epigenomics market 2022 & 2032 (USD Billion)
FIG 16. Europe Epigenomics market 2022 & 2032 (USD Billion)
FIG 17. Asia Pacific Epigenomics market 2022 & 2032 (USD Billion)
FIG 18. Latin America Epigenomics market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Epigenomics market 2022 & 2032 (USD Billion)
FIG 20. Global Epigenomics market, company market share analysis (2023)
…..
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.
